Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Jan 2021 - Dec 2021
Lobbyists (Full time equivalent)
0.2 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Ipsen Pharma
EU Transparency Register
84295189159-07 First registered on 15 Jul 2012
Goals / Remit
Ipsen is a leading biopharmaceutical group dedicated to improving lives through innovative medicines in oncology, neuroscience and rare diseases.
Main EU files targeted
Medicinal products for human use
Research and Development in life sciences
Horizon Europe
Intellectual Property Rights
Pharmaceutical Incentives
Brexit
European Green Deal
Industry Strategy
Pharmaceutical Strategy
Europe's Beating Cancer Plan
European Health Technology Assessment
Multiannual Financial Framework
EU Trade AgreementsAddress
Head Office
65, quai Georges Gorse
Boulogne-Billancourt 92650
FRANCEEU Office
Square de Meeus
Brussels 1000
BELGIUMWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 10% 2 Lobbyists (Full time equivalent)
0.2
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 17 Oct 2022
Name Start date End Date Loubna Ouriaghli 15 Nov 2023 14 Nov 2024 Ms Loubna Ouriaghli 15 Nov 2023 15 Apr 2024 Ms Loubna Ouriaghli 18 Oct 2022 14 Oct 2023 Ms Heloise LEVALLOIS 14 Sep 2019 12 Sep 2020 Mr Jan SWIDERSKI 24 May 2018 24 May 2019 Ms Heloise LEVALLOIS 28 Apr 2018 27 Apr 2019 Ms Heloise LEVALLOIS 15 Sep 2016 15 Sep 2017 Mr Giovanni Asta 06 Sep 2016 07 Sep 2017 Mr Jan SWIDERSKI 05 Sep 2016 01 Sep 2017 Ms Heloise LEVALLOIS 10 Sep 2015 08 Sep 2016 Mr Giovanni Asta 17 Jul 2015 15 Jul 2016 Mr Jan SWIDERSKI 17 Jul 2015 15 Jul 2016 Mr Giovanni Asta 05 Jul 2014 03 Jul 2015 Mr Jan SWIDERSKI 28 Jun 2014 26 Jun 2015 Complementary Information
2 Ipsen employees spend less than 10% of their time on activities covered by the Register.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Ipsen Pharma is a member of several organisations that may engage in activities covered by the Register:
- IFPMA
- EFPIA
- EuropaBio
- EBE
- PhRMA
- G5 SantéMember organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2021 - Dec 2021
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
100,000€ - 199,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
N/A
Other activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 29 Nov 2017 Location Brussels Subject Pharmaceutical incentives, antimicrobial resistance Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists